Healthcare Healthtech & Medtech M&A Transactions

Lexitas Pharma Services acquires Erie Retina Research and related entities, enhancing its specialized ophthalmology clinical trial services and retina research expertise.

BellaMia Technologies

BellaMia Technologies merges with Dominion Aesthetic Technologies for $200 million, forming a leading force in advanced medical aesthetics laser and robotic devices.

Endologix enhances its vascular disease treatment offerings by acquiring the FDA-cleared Pounce Thrombectomy System from Surmodics.

Cohere strengthens its enterprise AI platform with Reliant AI acquisition, boosting capabilities in secure biopharma and healthcare solutions.

GHO

GHO and CBC Group combine forces to launch a $21 billion global healthcare investment platform, driving innovation in life sciences and medtech.

GHO Capital

GHO Capital and CBC Group unite, creating a $21B powerhouse in healthcare investments, offering diverse private equity, credit, and infrastructure strategies globally.

SERB Pharmaceuticals secures European and MENA rights for Hansa Biopharma's Idefirix® (imlifidase) in a €115M deal, enhancing kidney transplant options.

SERB Pharmaceuticals secures European and MENA rights for Hansa Biopharma's imlifidase, a key therapy for highly sensitized kidney transplant patients, in a €115M deal.

Cohere strengthens its healthcare AI capabilities by acquiring Reliant AI, integrating specialized biomedical data and expertise into its enterprise platform.

The Pennant Group expands its senior living footprint with the acquisition of Copper Canyon Memory Care in Tucson, Arizona. Learn more about this strategic move.

Stone exits Dental Office as Capim acquires the firm. Learn about Stone's strategic realignment and focus on core financial services.

Private equity firms EQT and IDG Capital are in advanced talks to acquire Swiss peptide therapeutics manufacturer PolyPeptide, valued near $1.6 billion.

Qualtrics expands its AI-powered experience management platform with the $6.75 billion acquisition of Press Ganey Forsta, boosting its healthcare data capabilities.

Neurocrine Biosciences strengthens rare disease portfolio with $2.9B acquisition of Soleno Therapeutics and its PWS treatment, VYKAT XR.

Coastal Medical Transportation Systems enhances its regional medical transport capabilities with the acquisition of Alert Ambulance Service, strengthening its network.

EQT AB and IDG Capital are shortlisted to acquire Swiss peptide drug manufacturer PolyPeptide Group, valued at $1.6 billion. Altaris also remains in talks.

Embecta Corp. finalizes acquisition of Owen Mumford Holdings Limited, expanding its medical device and drug delivery technology portfolio.

Tecomet

Tecomet and Orchid Orthopedic Solutions unite, forming a scaled global manufacturing platform for MedTech and Aerospace. Enhanced capabilities and supply resilience.

H.I.G. Capital secures controlling interest in Vítaly, set to merge with Grupo Avanta, creating a major force in European workplace safety services.

Orthopaedic Specialty Group

Orthopaedic Specialty Group and OrthoConnecticut unite, creating a comprehensive, physician-led musculoskeletal care network across Connecticut.

IKS Health strengthens its healthcare AI platform by acquiring ARAI Solutions, boosting clinical reasoning and explainable AI capabilities for health organizations.

OrganaBio secures Excellos' assets, establishing a bicoastal cell therapy CDMO to address critical manufacturing and supply chain needs.

Zydus Worldwide DMCC, a Zydus Lifesciences subsidiary, acquires Assertio Holdings for $166.4M in an all-cash transaction, offering a substantial premium.

Function integrates SuppCo's supplement analysis with its biological testing platform, enhancing health transparency and personalized wellness insights.

H.I.G. Capital's Avanta Salud merges with Vitaly Group, forming a dominant force in Iberian occupational health and safety with significant scale and tech integration.

Avanta

HIG Capital acquires Vitaly and merges with Avanta, forming a leading Spanish occupational risk prevention group with an estimated €1 billion valuation.

HealthScape Advisors, a Chartis company, has acquired PayerAlly to bolster its pharmacy benefit management advisory services and address escalating healthcare costs.

Rialtic

Rialtic and Exponential AI unite, creating a powerful AI-driven platform to enhance healthcare payment accuracy and efficiency for payers and providers.

Cellular Intelligence

Cellular Intelligence acquires Parkinson's cell therapy rights from Novo Nordisk, leveraging AI for faster development and manufacturing. Backed by Khosla Ventures, CZI, SciFi VC, AMD Ventures.

Saesco Medical, with Miura Partners' support, strengthens its Italian market position by acquiring Medcomp, enhancing its medical device distribution capabilities.

Eli Lilly's $3.25B acquisition of Kelonia Therapeutics bolsters its oncology pipeline with advanced CAR-T technology. Learn about this strategic biotech deal.

Medit expands its digital dentistry footprint by acquiring Progressive Orthodontics and launching a dedicated Global Orthodontic Business Division.

EGYM

Major German startup exits in early 2026, including EGYM, Talon.One, and Blacklane, highlight ecosystem growth and value creation across tech, health, and mobility sectors.

Altor Fund V's Snark BidCo AB offers 24.50 SEK per share for Sleep Cycle AB, valuing it at 497 MSEK and signaling a move to create a wellness conglomerate.

Archimed's Cardioline Holding acquires Brazil's Cardios from Halma plc, enhancing its global footprint in cardiac diagnostics and telecardiology.

Bayer's $2.45B acquisition of Perfuse Therapeutics bolsters its ophthalmology pipeline with a novel treatment for glaucoma and diabetic retinopathy.

Angelini Pharma acquires Catalyst Pharmaceuticals for $4.1B, significantly expanding its U.S. rare disease and neurological disorder footprint.

Aurica Search Fund I completes its fifth investment with the acquisition of Super's Diana, a Spanish animal health company, via Rigi Capital Partners.

Rigi Capital acquires Super's Diana, a Catalan animal health company, with support from Aurica Search Fund. Details on deal and market impact.

Roche buys PathAI for up to $1.05 billion, boosting its AI-driven diagnostics and companion diagnostics capabilities for enhanced biomarker discovery and patient outcomes.